Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2026

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


		March 31, 2026				December 31, 2025
Prepaid research and development		$	2,559			$	2,460
Prepaid clinical trial			1,317				866
Deferred offering costs			195				195
Prepaid insurance			143				108
Other			1,011				802
Total prepaid expenses and other current assets		$	5,225			$	4,431

Schedule of Property Plant and Equipment Net

Property, plant and equipment, net consisted of the following (in thousands):


		March 31, 2026				December 31, 2025
Leasehold improvements		$	2,152			$	2,152
Laboratory equipment			3,357				3,306
Computer equipment			758				749
Furniture and fixtures			921				921
Construction in progress			4,236				4,292
			11,424				11,420
Accumulated depreciation			(4,974	)			(4,684	)
Property, plant and equipment, net		$	6,450			$	6,736

Schedule of Accrued Expense and Other Current Labilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


		March 31, 2026				December 31, 2025
Accrued research and development		$	4,851			$	3,591
Accrued compensation			2,988				9,425
Accrued clinical trial			3,879				3,290
Lease liabilities, current portion			1,824				1,865
Accrued professional and consulting fees			1,208				1,310
Accrued property, plant and equipment			—				19
Other			784				777
Total accrued expenses and other current liabilities		$	15,534			$	20,277